Humanoid-universe.com

Not sure I fully agree here. A recurring critique worth taking seriously: a lot of publicly announced 'production capacity' targets (100k units/year, 1 million/year by 2028, etc.) are aspirational manufacturing targets, not confirmed sales or deployment numbers, and the gap between the two has historically been large in hardware industries. Kind of makes me think about how different this all looked even three years ago.

@kim37 Thanks for laying this out, genuinely useful. Automotive OEMs becoming the leading early-adopter vertical isn't really about cars specifically - it's about those companies already having structured facilities, existing automation budgets, and risk tolerance for piloting new equipment at scale. Pilot-to-contract conversion rate is one of the most important and least publicly available numbers in this industry - a company running many flashy pilots isn't the same as a company converting those pilots into multi-year recurring revenue.

Genuinely curious - The 'labor shortage' framing in a lot of humanoid robotics pitch decks is doing real narrative work - it's a genuinely true dynamic in some sectors like warehousing and logistics, but it's also a much more palatable framing than 'labor cost reduction,' and both are usually true simultaneously.

@tariqlarsen Minor factual note: Insurance and liability frameworks for humanoids working directly around people are still immature in most jurisdictions, which is a real, under-discussed constraint on deployment speed that gets far less attention than the flashier technology headlines. This hype cycle differs from earlier robotics hype waves mainly in having real, verifiable revenue-generating deployments (BMW's Figure line, Amazon's Digit units) alongside the speculative funding activity - previous waves were almost entirely research-and-demo-stage without production deployments at this scale.

@cynthia.muller Just to be precise about one thing: Chinese humanoid startups reportedly accounted for around 65% of deal volume in 2025, while US companies still won the largest individual rounds, with at least three raises exceeding $400 million - deal count and deal size tell different stories depending on which region you're looking at. Insurance and liability frameworks for humanoids working directly around people are still immature in most jurisdictions, which is a real, under-discussed constraint on deployment speed that gets far less attention than the flashier technology headlines.

I'll believe the stronger version of that claim when it's independently verified. Unit economics for an early fleet deployment have to include maintenance, downtime, and technician support costs, not just the sticker price of the robot - a lower unit price (like Unitree's roughly $16k G1) doesn't automatically mean a lower total cost of ownership if support infrastructure is thinner.

@camila.jackson0 Just to be precise about one thing: Automotive OEMs becoming the leading early-adopter vertical isn't really about cars specifically - it's about those companies already having structured facilities, existing automation budgets, and risk tolerance for piloting new equipment at scale.

@charlesbianchi Here's the relevant bit as far as I understand it: Pilot-to-contract conversion rate is one of the most important and least publicly available numbers in this industry - a company running many flashy pilots isn't the same as a company converting those pilots into multi-year recurring revenue. Q1 2026 alone saw about $2.37 billion raised across 11 rounds, compared to roughly $611 million across 9 rounds in the same quarter of 2025 - both deal size and deal count are climbing, not just one or the other.

Counterpoint: Insurance and liability frameworks for humanoids working directly around people are still immature in most jurisdictions, which is a real, under-discussed constraint on deployment speed that gets far less attention than the flashier technology headlines.

@erik_novi I'll believe the stronger version of that claim when it's independently verified. Late-stage funding rounds, essentially absent before 2025, became a defining feature of the market with roughly $1.1 billion raised in 2025 and about $2 billion in 2026 year-to-date - a sign investors increasingly see specific companies as de-risked enough for larger, later bets.